搜索临床试验以:capecitabine camrelizumab apatinib
总计4197个结果
-
Cyclacel Pharmaceuticals, Inc.M.D. Anderson Cancer Center未知
-
Latin American Cooperative Oncology GroupGlaxoSmithKline完全的管理系统1 | 开始研究的绩效状态为零到二 | 接受最多一次化疗的患者 | 紫杉烷类药物后进展的患者阿根廷, 巴西, 秘鲁
-
Jiangsu HengRui Medicine Co., Ltd.完全的局部晚期或转移性和不可切除的 HCC美国, 西班牙, 中国, 台湾, 比利时, 大韩民国, 意大利, 香港, 俄罗斯联邦, 乌克兰, 火鸡, 波兰, 德国
-
Fujian Medical University尚未招聘
-
Fujian Cancer HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.; SunWay Biotech Co., LTD.尚未招聘肝转移 | 恶性黑色素瘤
-
Jiangsu HengRui Medicine Co., Ltd.未知
-
Peking University Cancer Hospital & Institute招聘中
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.未知
-
Hospital of Stomatology, Wuhan UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
University of Wisconsin, MadisonGlaxoSmithKline完全的
-
Azienda Socio Sanitaria Territoriale degli Spedali...招聘中
-
The First Affiliated Hospital of Zhengzhou UniversityJiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.未知
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Novartis Pharmaceuticals完全的
-
Sponsor GmbHGlaxoSmithKline; iOMEDICO AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische...终止
-
University of LiverpoolImperial College London; Newcastle University; University of Glasgow未知
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Shanghai Ninth People's Hospital Affiliated to...招聘中
-
Zhejiang Cancer Hospital尚未招聘
-
Hebei Medical University Fourth Hospital招聘中
-
Shanghai Junshi Bioscience Co., Ltd.主动,不招人
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
First Affiliated Hospital of Zhejiang University尚未招聘
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New Zealand主动,不招人
-
Bristol-Myers Squibb终止
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University尚未招聘